Diabetes awareness coverage tells readers to check their blood sugar and their A1C. MB's November 5 package covered A1C, the care team, cost and technology. This article goes down the leg, to a part of the body that most diabetes checklists reduce to a single line: the foot. The question is what happens, and who is responsible, between that line on the checklist and a lost limb.
The thesis is this. The annual foot exam is easy to record, and the research suggests it is delivered unevenly. What happens after the exam is where limbs are won or lost: classifying risk, checking circulation, referring to podiatry or vascular care, and tracking whether the referral was completed. Amputation rates in the United States differ by race, ethnicity, insurance and place, and the reviews attribute part of those differences to unequal access to care and to different rates of attempted limb preservation.
This article describes groups and systems as the studies define them. It does not describe any individual or clinic.
AN ILLUSTRATIVE SCENARIO (NOT A REAL PERSON) This is a composite built to organize questions. It is not someone MB interviewed, and it does not describe an actual clinic. An adult with type 2 diabetes goes to routine visits for years. The visit template includes a line reading “foot exam,” and it is marked complete. The record does not show what the exam covered, whether anyone tested sensation or circulation, whether the person was classified as low or high risk, or who would look at the feet next. A small sore appears under a toe. It does not hurt, because sensation in the foot has faded. Weeks pass before it is seen. Every step in this composite could be done correctly in some systems. The sections below ask what the research says about how often each step is done, and by whom. |
Why the foot
A 2023 review in Diabetes Care describes the lifetime risk of a diabetic foot ulcer as 19% to 34%. After an ulcer, recurrence is 65% at three to five years, lifetime lower-extremity amputation incidence is 20%, and five-year mortality is 50% to 70%. The authors write that the pathway to ulceration, involving loss of sensation, ischemia and minor trauma, is well established, and that amputation and death after an ulcer are late-stage complications.[1] It is a narrative review, so its figures summarize other studies.
A 2022 review of multidisciplinary diabetic foot care reports that rates of any amputation among U.S. people with diabetes fell through the 1990s and 2000s to about 0.3% per year, then turned. In the past decade, retrospective series report up to a 60% increase in minor amputations and up to a 30% increase in major amputations in some groups and regions, and more than 150,000 amputations were performed in U.S. adults with diabetes in 2018, a crude annual incidence near 0.6%.[2] The authors state that most major amputations are avoidable with appropriate care.[2]
More recent state-level data point the same way. An Illinois analysis of hospital admissions found 30,834 amputation admissions in non-federal hospitals from 2016 to 2023, an increase of 65%. The largest percent increases were among males (76.1%), non-Hispanic Black residents (67.5%) and residents aged 65 to 74. The authors report that through-foot amputations rose 129.4% and that their high-to-low amputation ratio fell from 1.83 to 1.04.[10] This is one state, based on hospital discharge records, and it excludes isolated toe amputations.
What the guideline asks for
The 2023 guideline from the International Working Group on the Diabetic Foot (IWGDF) on preventing foot ulcers recommends that a person with diabetes at very low risk of ulceration be screened annually for loss of protective sensation and peripheral artery disease, and that people at higher risk be screened more frequently for additional risk factors. It recommends foot self-care education for people at risk, treatment of pre-ulcerative lesions, therapeutic footwear for people at moderate to high risk, and integrated foot care for moderate- to high-risk people to help prevent ulcers from forming or returning.[3] The IWGDF's companion practical guideline describes the organizational levels needed to deliver prevention and care, and its authors say they believe implementing these principles is associated with fewer amputations.[4]
Two details matter for the process. First, the guideline's frequency depends on risk category, so the exam has to produce a classification that someone acts on. Second, a joint IWGDF, European Society for Vascular Surgery and Society for Vascular Surgery guideline states that approximately 50% of people with diabetes and a foot ulcer have peripheral artery disease, which significantly raises the risk of adverse limb events.[5] The multidisciplinary care review adds that in diabetes the ankle-brachial index can be unreliable because of noncompressible arteries, and that palpable pedal pulses can coexist with ischemia, so toe pressures and transcutaneous oximetry are emphasized where available.[2] A pulse check alone may miss disease.
Is the exam happening?
A study of the National Health and Nutrition Examination Survey (NHANES) for 2011 to 2018 included 2,836 adults with diabetes. Of them, a weighted 71.6% reported a foot examination by a medical professional in the past year. After adjustment, Hispanic adults were less likely than White adults to report one (adjusted odds ratio 0.685, 95% confidence interval 0.52 to 0.90). Black adults were not significantly different (1.11, 0.83 to 1.49). Having health insurance was associated with much higher odds (3.02, 2.27 to 4.03), and age 65 or older with higher odds (1.42, 1.05 to 1.92).[6] This is self-reported, and the survey question does not reveal what the exam included.
A broader NHANES analysis of 4,069 adults with diabetes from 2005 to 2018 tracked five elements of care recommended by the American Diabetes Association: a primary doctor with one or more visits, A1C testing, an eye exam, a foot exam and cholesterol testing. The share receiving all five by self-report rose from 25.0% in 2005-2006 to 34.1% in 2017-2018. It rose significantly only among adults 65 and older. People who did not receive all five were more likely to be younger, of lower socioeconomic status, uninsured and newly diagnosed.[7] That figure is for the five elements together, not the foot exam alone.
One result in the first NHANES study deserves attention. Black adults did not report fewer foot exams than White adults, yet, as the next section shows, Black patients with foot ulcers have higher amputation rates in several datasets. The studies do not link the two measurements for the same people, so they cannot settle the matter. The pattern does suggest that a recorded exam alone does not account for the differences in amputation, and that what follows the exam may matter at least as much.
Amputation: who, and where
| Study | Who and when | What it found |
|---|---|---|
| Tan et al., 2020[8] | 92,929 fee-for-service Medicare beneficiaries with a new foot ulcer or infection, 2011-2015 | Compared with White beneficiaries, African American (adjusted hazard ratio 1.9) and Native American (1.8) beneficiaries had higher risk of major amputation. Diagnosis in an outpatient visit, or by a podiatrist or primary care physician, was associated with lower risk |
| Mittal et al., 2026[9] | 388,371 adults with a foot ulcer in the TriNetX network, 2002-2019, matched on comorbidities | Hispanic and African American patients had higher major amputation risk (3.0% to 4.7% versus about 2.7% for matched White patients); Asian patients had the lowest risk; disparities persisted after adjustment for comorbidities and peripheral artery disease |
| Eakers et al., 2025[11] | 38,610 hospitalized patients aged 60 to 65 with a foot ulcer or infection, 2015-2019 | Uninsured patients had higher odds of amputation (adjusted odds ratio 1.20); Black, Hispanic and Asian or Pacific Islander identity were each associated with higher odds |
| Reilly et al., 2025[10] | Illinois amputation admissions, 2016-2023 | Rates rose most for non-Hispanic Black residents (67.5%), males and residents 65 to 74 |
The multidisciplinary care review summarizes the wider literature: even after adjusting for clinical risk, Black and Hispanic populations have 1.5- to 5-fold higher rates of amputation, and low rates of revascularization and a higher likelihood of amputation within a year of ulcer diagnosis suggest inequities in attempts at limb preservation.[2] A Seminars in Vascular Surgery review reports that the burden of disability and early death after major amputation is more prevalent in racial and ethnic minority groups, people with low socioeconomic status, and people in regions where distance from specialty care is a barrier.[15] These are reviews, and the primary studies above are retrospective, based on records and codes that do not capture ulcer stage or the reason a limb was or was not revascularized.
Mittal and colleagues also reported that Native American patients had the highest ratio of major to minor amputations despite no significant increase in major amputation risk. The authors suggest this may reflect differences in disease presentation or access to limb-preservation care and call for further study.[9]
Geography complicates the picture
Place matters, but not in a single direction. A county-level study of the Rio Grande Valley of Texas, using 2011 to 2016 data, found that the Valley's population with diabetes had a higher risk of diabetes-related lower-limb amputation than the rest of Texas (1.334, 95% confidence interval 1.291 to 1.378). Hispanic ethnicity was associated with higher county-level risk (2.172, 2.097 to 2.248). When Hispanic ethnicity was taken into account, living in the Valley was associated with lower risk (0.827, 0.795 to 0.86).[12] This is an ecological analysis of county rates, which cannot show what is true for any individual, and the abstract does not explain the protective association.
A 2026 study of Georgia counties in 2020 compared rural counties (population under 50,000) with urban ones. Rural counties had more poverty, lower median income and a higher prevalence of diabetes, hypertension, smoking and peripheral artery disease, and a higher incidence of amputations per 100,000 residents.[13] It is a single-year, single-state descriptive comparison. The multidisciplinary care review adds that rurality is associated with advanced-stage ulcers at presentation and with major amputation, and that clusters of high amputation rates have also been described in lower-income, majority-Black urban neighborhoods in cities with large academic medical centers, which the review reads as a gap between availability and use.[2]
Where the process breaks
Three questions run through the research: who does the exam, who refers, and who tracks the result.
Who does it. The 2020 Medicare study found that when an ulcer or infection was diagnosed by a podiatrist or primary care physician, major amputation risk was lower than when a specialist made the diagnosis (adjusted hazard ratio 0.7), and lower still when diagnosis happened at an outpatient visit rather than during an inpatient stay (0.3).[8] The abstract does not report ulcer stage, so this may reflect how advanced the problem was when it was found, and it does not show that any one specialty is better.
Who refers. A 2024 study in JAMA Network Open followed 14,935 Medicare beneficiaries with type 2 diabetes on dialysis who had a new foot ulcer. Only 18.4% had received podiatrist foot and ankle care in the three months before the diagnosis. Those who did had an 11% lower likelihood of death or major amputation (hazard ratio 0.89, 95% confidence interval 0.84 to 0.93) and a 9% lower likelihood of major amputation alone (0.91, 0.84 to 0.99).[14] This is an observational study. People who see a podiatrist may differ in ways the analysis could not fully capture, so it supports an association.
Who tracks. The multidisciplinary care review states that inability to access timely specialist care is a strong predictor of poor outcomes for non-White patients and low-income patients, and that standardized referral pathways can mitigate it. It also notes that when separate referrals are required, delays are more likely than in a multidisciplinary clinic, where vascular surgery, podiatry and diabetes specialists work together.[2] The retrieved sources do not quantify how often referrals are placed and never completed. That absence is itself a finding: a hospital rarely measures the part of the process that is most likely to fall between departments.
| Step | The question | What the research says |
|---|---|---|
| The exam | Who removes the shoes and socks, tests sensation and circulation, and records a risk category? | About 72% of surveyed adults reported an exam;[6] the guideline ties follow-up frequency to risk[3] |
| The circulation check | Who tests for peripheral artery disease with measures that work in diabetes? | About half of people with an ulcer have it;[5] ankle-brachial index can mislead[2] |
| The referral | Who sends a high-risk foot to podiatry or vascular care, and by when? | Podiatrist care before an ulcer was associated with lower amputation risk in one cohort, but few received it[14] |
| The tracking | Who confirms the visit happened and the result came back? | Not measured in the retrieved studies; standardized pathways are recommended[2] |
| The payment | Who pays for the team and the footwear? | The review says current payment models do not sufficiently support multidisciplinary ulcer care[2] |
What limb-salvage teams show, and what they do not
The multidisciplinary diabetic foot care model, in which vascular surgery, podiatry and a diabetes physician work as one team with standardized screening, wound care, offloading and revascularization, is the intervention most associated with fewer amputations in this literature. The 2022 review states that a systematic review found 94% of publications examining before-and-after outcomes reported a reduction in major amputations, with up to a 51% absolute reduction in some reports. It also reports that centers serving underserved urban populations have shown healing and limb-preservation outcomes comparable with those of higher-income populations, and that in similar settings neither race nor insurance was associated with adverse outcomes.[2]
The same review is candid about limits. The evidence is mostly retrospective, center-based, before-and-after cohorts. No clear data exist on the required components of such a team. Minor amputations are not necessarily reduced, and in several studies they increased, which the authors interpret as higher rates of preserved function. Access remains a barrier, and the authors conclude that availability does not guarantee use, and that outreach, referral networks and reimbursement are needed.[2] The strongest evidence comes from the places that built the teams.
WHAT THE EVIDENCE CAN AND CANNOT TELL US Can tell us: amputation risk differs by race, ethnicity, insurance and place across several large datasets, and some differences persist after matching or adjustment. Guidelines tie screening frequency to risk category. Multidisciplinary teams are associated with fewer major amputations in many center-based reports. Cannot tell us: how often an exam includes sensation and circulation testing. The national data on foot exams are self-reported and do not describe content. Cannot tell us: why any group has higher amputation rates. The datasets use diagnostic codes and cannot capture ulcer stage, the reason a limb was or was not revascularized, or what happened between visits. Cannot tell us: how often referrals are placed and never completed. MB did not retrieve a U.S. population estimate. Cannot tell us: that a multidisciplinary team causes the reduction. Most reports are before-and-after comparisons at the centers that built the teams. Not retrieved: MB did not retrieve the text of the American Diabetes Association's foot care standards, so this article relies on the IWGDF guideline for recommendations. A foot-exam completion measure used by health plans or health systems was not retrieved either. |
QUESTIONS TO ASK ABOUT YOUR FEET (FOR PATIENTS, FAMILIES AND ADVOCATES) At my last visit, were my shoes and socks taken off? Was my sensation tested, and were my pulses or circulation checked? What is my foot risk category? How often does that category say I should be seen? Who is my go-to person for a foot problem, and what number do I call if I see a sore, a blister, a color change or swelling? Do I need podiatry or a vascular evaluation? Who places the referral, and who will tell me if it has not been scheduled? Do I have shoes or inserts that fit, and who helps with the cost? Does this practice or hospital have a team that treats foot wounds together? If a wound is not healing, how fast can I be seen? Is anyone checking that the referral visit actually happened? |
What MB will ask next: in the hospitals and clinics we cover, who examines the feet of patients with diabetes, what counts as a completed exam, and is the result classified by risk? Who places a referral to podiatry or vascular care, and does anyone confirm the visit happened? Do completion data exist by race, ethnicity, insurance and neighborhood? If the data exist, we will publish what they show. If they do not, that is part of the story.
General information, not individual medical advice. For emergencies, seek immediate help. The conversation continues.
Sources (Peer-Reviewed Work Retrieved From Pubmed; Doi Links Included)
[1] McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care. 2023;46(1):209-221. DOI: https://doi.org/10.2337/dci22-0043 (PMID 36548709). Narrative review. Abstract retrieved.
[2] McDermott KM, Srinivas T, Abularrage CJ. Multidisciplinary approach to decreasing major amputation, improving outcomes, and mitigating disparities in diabetic foot and vascular disease. Semin Vasc Surg. 2023;36(1):114-121 (online 2022). DOI: https://doi.org/10.1053/j.semvascsurg.2022.11.001 (PMID 36958892). Narrative review. Full text retrieved from PubMed Central.
[3] Bus SA, Sacco ICN, Monteiro-Soares M, Raspovic A, Paton J, Rasmussen A, Lavery LA, van Netten JJ. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3651. DOI: https://doi.org/10.1002/dmrr.3651 (PMID 37302121). Guideline. Abstract retrieved.
[4] Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Fitridge R, Game F, Monteiro-Soares M, Senneville E. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3657. DOI: https://doi.org/10.1002/dmrr.3657 (PMID 37243927). Guideline. Abstract retrieved.
[5] Fitridge R, Chuter V, Mills J, Hinchliffe R, Azuma N, Behrendt CA, Boyko EJ, Conte MS, et al. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer. Eur J Vasc Endovasc Surg. 2023;66(4):454-483. DOI: https://doi.org/10.1016/j.ejvs.2023.07.020 (PMID 37724984). Guideline. Abstract retrieved.
[6] Fermawi SA, Tolson JP, Knapp SM, Marrero D, Zhou W, Armstrong DG, Tan TW. Disparities in preventative diabetic foot examination. Semin Vasc Surg. 2023;36(1):84-89. DOI: https://doi.org/10.1053/j.semvascsurg.2023.01.001 (PMID 36958902). Cross-sectional analysis of NHANES 2011-2018, self-reported. Abstract retrieved.
[7] Shin JI, Wang D, Fernandes G, Daya N, Grams ME, Golden SH, Rajpathak S, Selvin E. Trends in receipt of American Diabetes Association guideline-recommended care among U.S. adults with diabetes: NHANES 2005-2018. Diabetes Care. 2021;44(6):1300-1308. DOI: https://doi.org/10.2337/dc20-2541 (PMID 33863753). Serial cross-sectional analysis, self-reported. Abstract retrieved.
[8] Tan TW, Armstrong DG, Concha-Moore KC, Marrero DG, Zhou W, Calhoun E, Chang CY, Lo-Ciganic WH. Association between race/ethnicity and the risk of amputation of lower extremities among Medicare beneficiaries with diabetic foot ulcers and diabetic foot infections. BMJ Open Diabetes Res Care. 2020;8(1). DOI: https://doi.org/10.1136/bmjdrc-2020-001328 (PMID 32843499). Retrospective cohort, 5% Medicare sample. Abstract retrieved.
[9] Mittal MM, Tummala S, Raspovic KM, Johnson MJ, Sambandam SN, Boulton AJM, Armstrong DG, Wukich DK. Examining racial disparities in lower extremity amputation outcomes among patients with diabetic foot ulcers in North America: a multicohort study. Adv Wound Care. 2026. DOI: https://doi.org/10.1177/21621918261501839 (PMID 42978104). Retrospective propensity-matched cohort (TriNetX). Abstract retrieved.
[10] Reilly MA, Cohen IC, Watson SL, Minc SD, Ho KJ, Feinglass J. A population health analysis of trends in lower extremity amputation secondary to diabetes and peripheral artery disease, 2016-2023. Diabetes Res Clin Pract. 2025;230:112963. DOI: https://doi.org/10.1016/j.diabres.2025.112963 (PMID 42678519). Observational cohort of hospital admissions, Illinois. Abstract retrieved.
[11] Eakers GM, Sarwar Z, Nassar Z, Farnell C, Greif BA, Bonds MM. Patient insurance status and race modify outcomes for diabetic patients undergoing care for diabetic foot ulcers and infections. Ann Vasc Surg. 2025;122:267-273. DOI: https://doi.org/10.1016/j.avsg.2025.07.013 (PMID 40683419). National Inpatient Sample analysis. Abstract retrieved.
[12] Collazo A, Shibuya N, Prochaska J, Jupiter DC. Diabetes-related lower limb amputations in the Rio Grande Valley of Texas: a focused look at a historical health disparity. J Racial Ethn Health Disparities. 2025;13(2):889-900. DOI: https://doi.org/10.1007/s40615-025-02301-3 (PMID 39946083). County-level ecological analysis. Abstract retrieved.
[13] Stegall A, Hitchcock B, Patrick K, Radcliff J, Solis MM, Jean-Jacques E. Does geographic disadvantage increase lower extremity amputation risk in the state of Georgia? J Surg Res. 2026;328:460-465. DOI: https://doi.org/10.1016/j.jss.2026.09.044 (PMID 42976765). County-level descriptive analysis. Abstract retrieved.
[14] Tan TW, Caldwell B, Zhang Y, Kshirsagar O, Cotter DJ, Brewer TW. Foot and ankle care by podiatrists and amputations in patients with diabetes and kidney failure. JAMA Netw Open. 2024;7(3):e240801. DOI: https://doi.org/10.1001/jamanetworkopen.2024.0801 (PMID 38427353). Retrospective cohort, US Renal Data System. Abstract retrieved.
[15] McDermott KM, Bose S, Keegan A, Hicks CW. Disparities in limb preservation and associated socioeconomic burden among patients with diabetes and/or peripheral artery disease in the United States. Semin Vasc Surg. 2023;36(1):39-48. DOI: https://doi.org/10.1053/j.semvascsurg.2023.01.007 (PMID 36958896). Narrative review. Abstract retrieved.
